Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Philippe Maillet"'
Publikováno v:
Disease Markers. 32:343-353
Background: BRCA1andBRCA2germline mutations predispose heterozygous carriers to hereditary breast/ovarian cancer. However, unclassified variants (UVs) (variants with unknown clinical significance) and missense polymorphisms inBRCA1andBRCA2genes pose
Autor:
Maria J. Soares, Mauricio Magalhaes Costa, Ingrid Petroni Ewald, Rachel Kyle, Nelly Sabbaghian, Torben A Kruse, Leonor Gusmão, Mads Thomassen, Silvia Casadei, Annemarie H. van der Hout, Marc Tischkowitz, Patrícia Rocha, Ana Vega, Miguel de la Hoya, Patricia Ashton-Prolla, Lone Sunde, Sara Gutiérrez-Enríquez, Dirce Maria Carraro, Conxi Lázaro, Philippe Maillet, Maroulio Pertesi, Cindy Benson, Pedro Pinto, Alberto Gulino, Nancy Uhrhammer, Drakoulis Yannoukakos, William D. Foulkes, Lucie Cornil, Etienne Rouleau, Ana Peixoto, Ignacio Blanco, Gaelle Benais-Pont, Robert Royer, Mary Claire King, Montserrat Baiget, Thangarajan Rajkumar, María Dolores Miramar, Ana Rodriguez Valle, Maria Teresa Calvo, Judith Balmaña, Anne-Marie Gerdes, Rosette Lidereau, Giuseppe Giannini, Catarina Santos, Eladio Velasco, Maria Isabel Achatz, Dorthe G. Crüger, Luisa Mota-Vieira, Carmen Alonso, Orland Diez, Eitan Friedman, Manuela Pinheiro, Brigitte Bressac-de Paillerets, Yael Laitman, Steven A. Narod, Teresa Ramón y Cajal, Begoña Graña, António Amorim, Trinidad Caldés, Lídia Feliubadaló, Mercedes Durán, Bruno Pardo, Erik Teugels, Audrey Remenieras, Manuel R. Teixeira, Yves-Jean Bignon, Ana Blanco
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
Peixoto, A, Santos, C, Pinheiro, M, Pinto, P, Soares, M J, Rocha, P, Gusmão, L, Amorim, A, van der Hout, A, Gerdes, A-M, Thomassen, M, Kruse, T A, Cruger, D, Sunde, L E M, Bignon, Y-J, Uhrhammer, N, Cornil, L, Rouleau, E, Lidereau, R, Yannoukakos, D, Pertesi, M, Narod, S, Royer, R, Costa, M M, Lazaro, C, Feliubadaló, L, Graña, B, Blanco, I, de la Hoya, M, Caldés, T, Maillet, P, Benais-Pont, G, Pardo, B, Laitman, Y, Friedman, E, Velasco, E A, Durán, M, Miramar, M-D, Valle, A R, Calvo, M-T, Vega, A, Blanco, A, Diez, O, Gutiérrez-Enríquez, S, Balmaña, J, Ramon Y Cajal, T, Alonso, C, Baiget, M, Foulkes, W, Tischkowitz, M, Kyle, R, Sabbaghian, N, Ashton-Prolla, P, Ewald, I P, Rajkumar, T, Mota-Vieira, L, Giannini, G, Gulino, A, Achatz, M I, Carraro, D M, de Paillerets, B B, Remenieras, A, Benson, C, Casadei, S, King, M-C, Teugels, E & Teixeira, M R 2011, ' International distribution and age estimation of the Portuguese BRCA2 c.156_157insAlu founder mutation ', Breast Cancer Research and Treatment, vol. 127, no. 3, pp. 671-9 . https://doi.org/10.1007/s10549-010-1036-3
Peixoto, A, Santos, C, Pinheiro, M, Pinto, P, Soares, M J, Rocha, P, Gusmão, L, Amorim, A, van der Hout, A, Gerdes, A-M, Thomassen, M, Kruse, T A, Cruger, D, Sunde, L, Bignon, Y-J, Uhrhammer, N, Cornil, L, Rouleau, E, Lidereau, R, Yannoukakos, D, Pertesi, M, Narod, S, Royer, R, Costa, M M, Lazaro, C, Feliubadaló, L, Graña, B, Blanco, I, de la Hoya, M, Caldés, T, Maillet, P, Benais-Pont, G, Pardo, B, Laitman, Y, Friedman, E, Velasco, E A, Durán, M, Miramar, M-D, Valle, A R, Calvo, M-T, Vega, A, Blanco, A, Diez, O, Gutiérrez-Enríquez, S, Balmaña, J, Ramon Y Cajal, T, Alonso, C, Baiget, M, Foulkes, W, Tischkowitz, M, Kyle, R, Sabbaghian, N, Ashton-Prolla, P, Ewald, I P, Rajkumar, T, Mota-Vieira, L, Giannini, G, Gulino, A, Achatz, M I, Carraro, D M, de Paillerets, B B, Remenieras, A, Benson, C, Casadei, S, King, M-C, Teugels, E & Teixeira, M R 2011, ' International distribution and age estimation of the Portuguese BRCA2 c.156_157insAlu founder mutation ', Breast Cancer Research and Treatment, vol. 127, no. 3, pp. 671-9 . https://doi.org/10.1007/s10549-010-1036-3
Breast Cancer Research and Treatment, 127(3), 671-679. SPRINGER
BREAST CANCER RESEARCH AND TREATMENT
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Peixoto, A, Santos, C, Pinheiro, M, Pinto, P, Soares, M J, Rocha, P, Gusmão, L, Amorim, A, van der Hout, A, Gerdes, A-M, Thomassen, M, Kruse, T A, Cruger, D, Sunde, L E M, Bignon, Y-J, Uhrhammer, N, Cornil, L, Rouleau, E, Lidereau, R, Yannoukakos, D, Pertesi, M, Narod, S, Royer, R, Costa, M M, Lazaro, C, Feliubadaló, L, Graña, B, Blanco, I, de la Hoya, M, Caldés, T, Maillet, P, Benais-Pont, G, Pardo, B, Laitman, Y, Friedman, E, Velasco, E A, Durán, M, Miramar, M-D, Valle, A R, Calvo, M-T, Vega, A, Blanco, A, Diez, O, Gutiérrez-Enríquez, S, Balmaña, J, Ramon Y Cajal, T, Alonso, C, Baiget, M, Foulkes, W, Tischkowitz, M, Kyle, R, Sabbaghian, N, Ashton-Prolla, P, Ewald, I P, Rajkumar, T, Mota-Vieira, L, Giannini, G, Gulino, A, Achatz, M I, Carraro, D M, de Paillerets, B B, Remenieras, A, Benson, C, Casadei, S, King, M-C, Teugels, E & Teixeira, M R 2011, ' International distribution and age estimation of the Portuguese BRCA2 c.156_157insAlu founder mutation ', Breast Cancer Research and Treatment, vol. 127, no. 3, pp. 671-9 . https://doi.org/10.1007/s10549-010-1036-3
Peixoto, A, Santos, C, Pinheiro, M, Pinto, P, Soares, M J, Rocha, P, Gusmão, L, Amorim, A, van der Hout, A, Gerdes, A-M, Thomassen, M, Kruse, T A, Cruger, D, Sunde, L, Bignon, Y-J, Uhrhammer, N, Cornil, L, Rouleau, E, Lidereau, R, Yannoukakos, D, Pertesi, M, Narod, S, Royer, R, Costa, M M, Lazaro, C, Feliubadaló, L, Graña, B, Blanco, I, de la Hoya, M, Caldés, T, Maillet, P, Benais-Pont, G, Pardo, B, Laitman, Y, Friedman, E, Velasco, E A, Durán, M, Miramar, M-D, Valle, A R, Calvo, M-T, Vega, A, Blanco, A, Diez, O, Gutiérrez-Enríquez, S, Balmaña, J, Ramon Y Cajal, T, Alonso, C, Baiget, M, Foulkes, W, Tischkowitz, M, Kyle, R, Sabbaghian, N, Ashton-Prolla, P, Ewald, I P, Rajkumar, T, Mota-Vieira, L, Giannini, G, Gulino, A, Achatz, M I, Carraro, D M, de Paillerets, B B, Remenieras, A, Benson, C, Casadei, S, King, M-C, Teugels, E & Teixeira, M R 2011, ' International distribution and age estimation of the Portuguese BRCA2 c.156_157insAlu founder mutation ', Breast Cancer Research and Treatment, vol. 127, no. 3, pp. 671-9 . https://doi.org/10.1007/s10549-010-1036-3
Breast Cancer Research and Treatment, 127(3), 671-679. SPRINGER
BREAST CANCER RESEARCH AND TREATMENT
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
9 páginas, 4 figuras, 1 tabla.-- El pdf del artículo es la versión pre-print.-- et al.
The c.156_157insAlu BRCA2 mutation has so far only been reported in hereditary breast/ovarian cancer (HBOC) families of Portuguese origin. Since this mutat
The c.156_157insAlu BRCA2 mutation has so far only been reported in hereditary breast/ovarian cancer (HBOC) families of Portuguese origin. Since this mutat
Publikováno v:
Disease Markers. 28:377-384
Background:Breast cancer is the leading cause of cancer death in women in Algeria. The contribution ofBRCA1andBRCA2mutations to hereditary breast/ovarian cancer in Algerian population is largely unknown. Here, we describe analysis ofBRCA1andBRCA2gene
Autor:
Mary Khoshbeen-Boudal, Philippe Maillet, David R. Betts, André-Pascal Sappino, Hulya Ozsahin, Fabienne Gumy-Pause
Publikováno v:
Leukemia Research, Vol. 32, No 8 (2008) pp. 1207-13
ATM gene alterations have been described in various lymphoproliferative malignancies suggesting that ATM contributes to lymphomagenesis. Using multiplex ligation-dependant probe amplification (MLPA), we screened 61 childhood lymphoid malignancies for
Autor:
Pierre Hutter, Jian Zhang, Claudine Rey Berthod, Karl Heinimann, Anna Russell, Judith Luz, Hansjakob Mueller, Pierre O. Chappuis, Philippe Maillet
Publikováno v:
International Journal of Cancer. 118:1937-1940
In 10–30% of patients with classical familial adenomatous polyposis (FAP) and up to 90% of those with attenuated (
Autor:
Gabriel Tamagnini, Letícia Ribeiro, Philippe Maillet, Helena Almeida, Mireille Deguillien, Madeleine Morinière, Jean Delaunay, Thérèse Cynober, François Delhommeau, Nicole Dalla Venezia, Faouzi Baklouti
Publikováno v:
ResearcherID
Europe PubMed Central
Scopus-Elsevier
Europe PubMed Central
Scopus-Elsevier
Early biochemical studies defined 4 functional domains of the erythroid protein 4.1 (4.1R). From amino-terminal to carboxy-terminal, these are 30 kd, 16 kd, 10 kd, and 22/24 kd in size. Although the functional properties of both the 30-kd and the 10-
A polymorphism in theATM gene modulates the penetrance of hereditary non-polyposis colorectal cancer
Autor:
Philippe Maillet, G. Vaudan, André-Pascal Sappino, Pierre Hutter, Z Dobbie, Hansjakob Müller, P O Chappuis
Publikováno v:
International Journal of Cancer. 88:928-931
Germ-line mutations in MLH1 and MSH2 genes predispose to hereditary non-polyposis colorectal cancer (HNPCC) syndrome, but they do not predict a specific phenotype of the disease. We speculated that the ataxia-telangiectasia mutated gene (ATM) was a c
Autor:
Raymond Miralbell, Pierre-André Doriot, Philippe Maillet, Nigel E.A. Crompton, Philippe Nouet, Monika Harms, Vitali Verin, Michel Rouzaud
Publikováno v:
Journal of Vascular and Interventional Radiology. 10:1190-1194
Publikováno v:
Leukemia Research, Vol. 30, No 3 (2006) pp. 335-7
ATM promoter hypermethylation has been recently reported in adult carcinomas, but no information is available concerning the methylation status of ATM gene promoter in childhood B-precursor acute lymphoblastic leukaemia (ALL). Furthermore, involvemen
Autor:
Elisabeth Laurent, Philippe Maillet, Raymond Dokhan, Akram Talab, Roland Ollivier, Youssef El Ahmad, and Gilles Tran, Jean François Teste
Publikováno v:
Journal of Medicinal Chemistry. 40:952-960
A series of 1-(benzocycloalkyl)-4-(benzamidolkyl)piperazine derivatives was prepared in order to obtain compounds with a high affinity and selectivity for 5-HT1A receptors. The modifications of aromatic substituents, the length of the alkyl chain, an